The Maudsley Bipolar Disorder Project: The Effect of Medication, Family History, and Duration of Illness on IQ and Memory in Bipolar I Disorder
J Clin Psychiatry 2003;64(1):86-93
© Copyright 2017 Physicians Postgraduate Press, Inc.
Purchase This PDF for $40.00
If you are not a paid subscriber, you may purchase the PDF.
(You'll need the free Adobe Acrobat Reader.)
Receive immediate full-text access to JCP. You can subscribe to JCP online-only ($86) or print + online ($156 individual).
With your subscription, receive a free PDF collection of the NCDEU Festschrift articles. Hurry! This offer ends December 31, 2011.
If you are a paid subscriber to JCP and do not yet have a username and password, activate your subscription now.
As a paid subscriber who has activated your subscription, you have access to the HTML and PDF versions of this item.
Click here to login.
Did you forget your password?
Still can't log in? Contact the Circulation Department at 1-800-489-1001 x4 or send email
Background: Despite the growing recognition of
the importance of cognitive impairment in psychiatric disorders,
the effect of clinical factors, such as medication use and family
history of affective disorders, on cognition in bipolar I
disorder patients still remains unclear. This study examines the
contribution of known and potential predictors to both general
intellectual function and memory in a representative population
of bipolar I disorder patients.
Method: Of the 425 patients receiving treatment
within a defined catchment area, 63 were identified as having
bipolar I disorder. Of these patients, 43 were enrolled in the
study and participated in a personal interview by a psychiatrist.
All patients were invited to participate in a personal interview
by a psychiatrist, and information on family history, past
psychiatric history, past and current treatments, duration of
illness, and age at onset was collected, in addition to
demographic data. Cognitive performance was assessed using the
Wechsler Adult Intelligence Scale-Revised, the National Adult
Reading Test, and the Wechsler Memory Test III.
Results: Forty-three patients with DSM-IV
bipolar I disorder were enrolled into the Maudsley Bipolar
Disorder Project. Patients on treatment with antipsychotic drugs
had a lower current full scale IQ, lower general memory scores,
and lower working memory scores. A family history of affective
disorders was associated with a higher full scale IQ, but not
with either general or working memory measures. Duration of
illness was negatively associated with general memory scores, but
had no effect on either IQ or working memory measures.
Conclusion: Current antipsychotic medication,
duration of illness, and family history of affective disorder
were the most significant predictors of IQ and memory function in
bipolar I disorder patients.